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Theneural crest is amultipotent stemcell-likepopula-
tion that is induced during gastrulation, but only
acquires its characteristic morphology, migratory
ability, and gene expression profile after neurulation.
This raises the intriguing possibility that precursors
are actively maintained by epigenetic influences in
a stem cell-like state. Accordingly, we report that
dynamic histone modifications are critical for proper
temporal control of neural crest gene expression
in vivo. The histone demethylase, JumonjiD2A
(JmjD2A/KDM4A), is expressed in the forming neural
folds. Loss of JmjD2A function causes dramatic
downregulation of neural crest specifier genes
analyzed by multiplex NanoString and in situ hybrid-
ization. Importantly, in vivo chromatin immunoprecip-
itation reveals direct stage-specific interactions of
JmjD2Awith regulatory regions of neural crest genes,
andassociated temporalmodifications inmethylation
states of lysine residues directly affected by JmjD2A
activity. Our findings show that chromatin modifica-
tions directly control neural crest genes in vertebrate
embryos via modulating histone methylation.
INTRODUCTION
The neural crest (NC) is a multipotent stem cell-like population
that migrates extensively and differentiates into diverse cell
types in vertebrate embryos. In the chick, neural crest induction
initiates during gastrulation (Basch et al., 2006), leading to estab-
lishment of a precursor population at the border between
presumptive neural and nonneural ectoderm. As the neural folds
elevate (stage 7), these border cells begin to express premigra-
tory neural crest markers. Finally, after neural tube closure
(stages 8–10), these cells become distinct and emigrate from
the central nervous system, migrating extensively and forming
numerous derivatives (Crane and Trainor, 2006; Knecht and
Bronner-Fraser, 2002).
A ‘‘hard-wired’’ gene regulatory network, formulated from data
derived from several model vertebrates, is thought to mediate
neural crest formation (Sauka-Spengler and Bronner-Fraser,
2008). Most notably, modules of transcription factors are
proposed to function in sequential fashion to first specify the
neural plate border and then the nascent neural crest. Finally,460 Developmental Cell 19, 460–468, September 14, 2010 ª2010 Elsthe process of neural crest differentiation involves the activity
of NC specifier genes including SoxE transcription factors
(Sox10 and Sox9), which regulate effector genes that imbue
neural crest derivatives with characteristics of terminal differen-
tiation (Sauka-Spengler and Bronner-Fraser, 2008). However,
little is known about the hierarchical relationships, direct regula-
tory interactions, or connections between these different
modules. The temporal gap between initial induction during
gastrulation (Basch et al., 2006) and final appearance of the
migratory, multipotent neural crest raises the fundamental
question of what maintains neural crest cells in an undifferenti-
ated, stem cell-like state in the intervening time.
The prolonged maintenance of stem cell properties is consis-
tent with an important role for chromatin modifications in spatio-
temporal control of the neural crest gene expression program.
In vitro studies of embryonic stem cells suggest that these
modification events may poise stem cell genes in a transcription-
ally ready state via modifications of N-terminal histone tails. For
example, histone methylation has been associated with both
transcriptional activation and repression (Kouzarides, 2007).
Whereas methylation of H3 lysines 4 and 36 (H3K4me2/me3
and H3K36me2/3) are enriched in transcriptionally active
euchromatic regions, H3 lysines 9 and 27 (H3K9me3 and
H3K27me3) are located in repressed sites (Nielsen et al., 2001;
Shi et al., 2003) as well as associated with heterochromatin
(Li et al., 2007; Nakayama et al., 2001; Peters et al., 2002).
Histone demethylases such as members of the Jumonji family
revert histone trimethylation (Tan et al., 2008). Unlike other
demethylases, JmjD2/KDM4 proteins have been shown to re-
move both lysine 9 and 36 trimethyl marks (Couture et al., 2007).
An intriguing possibility is that such chromatin modifiers may
play a critical role in the balance between differentiation and
stem cell like behavior at the neural plate border and forming
neural crest. However, little is known about the function of the
Jumonji family or other epigenetic modifiers in vivo in the devel-
oping vertebrate embryo. As an accessible embryonic stem cell
population, the neural crest offers an excellent experimental
system to probe the role of chromatin modification during
development in vivo.RESULTS
Jumonji Is Expressed at Key Times/Locations during
Neural Crest Development
The JmjD2/KDM4 subfamily consists of the JmjD2A-F genes,
though JmjD2E and F appear to be pseudogenes (Katoh,
2004) and only the JmjD2A-D proteins possess histoneevier Inc.
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Figure 1. JmjD2A Is Expressed at the Right
Time and Location to Play an Important
Role in Neural Crest Development
(A–F) Expression pattern of JmjD2A in the early
chick embryo by whole mount in situ hybridization
at stages 4–10. Transverse sections (dotted lines)
reveal specific expression in the neural plate at
stage 5 (B0); in neural plate, neural plate border
and nonneural ectoderm at stage 6 (C0); in dorsal
neural tube at stage 8 (E0); and at low levels in
migratory neural crest (evidenced by HNK-1 stain-
ing in red) at stage 10 (F0).
(G) Immunohistochemistry using an anti-JmjD2A
corroborates the protein expression at stage 8 in
dorsal neural tube and nonneural ectoderm.
(H) QPCR analyses show highest expression of
JmjD2A (black bars) at stage 5, decreasing there-
after in a manner reciprocal to that of the neural
crest specifier gene, Sox10 (solid line). JmjD2B
(gray bars) present low and constant expression
patter during the analyzed stages. Values repre-
sent the average of three samples run in triplicate
±SD. See also Figure S1.
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JmjD2A Is Essential for Neural Crest Specificationdemethylase activity (Cloos et al., 2006; Klose et al., 2006;
Whetstine et al., 2006). By in silico analysis, only JmjD2A-C
genes were detectable in the chick genome.
We examined the presence of all three transcripts by whole
mount in situ hybridization and quantitative polymerase chain
reaction (QPCR) from chick gastrulation through neural crest
migration (Figure 1; see Figure S1 available online). Of these,
JmjD2A demonstrated appropriate spatiotemporal expression
consistent with playing a role in neural crest development
(Figures 1A–1G). JmjD2A transcripts were observed in the neural
plate, neural plate border, and nonneural ectoderm (Figures 1A–
1C). JmjD2A initially is expressed throughout the neural plate,
partially overlapping with the neural plate border marker Pax7
(Basch et al., 2006) but resolves to the neural crest forming
region by stage 5/6. As the neural folds elevate, JmjD2A was
restricted to the dorsal neural folds, fromwhich neural crest cells
originate, as well as faintly expressed in nonneural ectoderm
(Figures 1D and 1E). Protein expression, as revealed by
a JmjD2A-specific antibody, paralleled that of the transcripts
(Figure 1G). After neural tube closure, only low levels of JmjD2A
expressionwere observed onmigrating HNK1+ neural crest cells
(Figure 1F). Parallel analysis by QPCR reveals the highest
expression of JmjD2A at stage 5, decreasing from stage 8
onward; this is reciprocal to the onset of Sox10 expression,
a key regulator of neural crest cell specification (Figure 1H).
In contrast to JmjD2A, JmjD2B was detected only by QPCR
and was expressed at low and constant levels (Figure 1H), and
JmjD2C was not detectable by either QPCR or in situ hybridiza-
tion at the stages examined (Figure S1). These data provide
anatomical and temporal evidence suggesting that JmjD2A
may be an important player in neural crest specification.
Overexpression of JmjD2A in Fibroblasts Specifically
Depletes H3K9me3 and H3K36me3
To define the lysine specificity of chick JmjD2A, a vector
containing the coding sequence of JmjD2A (JmjD2A-GFP)
under the control b-actin promoter was transfected into chicken
fibroblast cells (Figure S2). The results show that cells overex-Developmenpressing JmjD2A completely lack either H3K9me3 or
H3K36me3 marks; on the other hand, H3K27me3 methylation
marks remain expressed. This activity is dependent on an intact
JmjC domain, as amino acid substitutions (DJmjD2A-GFP:
G133A, G138A, G165A, G170A, S288N, and T289B) in the cata-
lytic domain (Chen et al., 2007) abrogate these effects. These
results demonstrate that JmjD2A is specific for H3K9me3 and
H3K36me3 substrates in these cells, consistent with previous
reports.
Loss of JmjD2A Leads to Depletion of Neural Crest
Specifier Genes
To examine the function of JmjD2A in neural crest specification,
we tested its developmental effects on gene expression by
a loss-of-function analysis using antisense morpholino oligonu-
cleotides (MO) to specifically block translation of JmjD2A
protein. We used two nonoverlapping fluorescein-tagged MOs,
one located just over the ATG codon and the second l38 nucle-
otides upstream of the start codon, with both yielding similar
effects. MOs plus carrier DNA were injected on the left half of
stage 4–5 embryos, such that the uninjected side served as an
internal control. Immunoblotting confirmed a marked reduction
of JmjD2A protein after morpholino knockdown on the injected
side (IS) compared with the uninjected side (UIS) of the same
embryos, as well as between the injected side of control-MO-
treated embryos (Figure 3C). Furthermore, there was no signifi-
cant change in either cell proliferation (p = 0.29, n = 5) or cell
death (p = 0.32, n = 5), as assayed by TUNEL and phosphohi-
stone 3 staining (Figure S4B).
As a first step in assessing the effects of JmjD2A on a wide
array of downstream genes, we used the NanoString nCounter
technology (Fortina and Surrey, 2008) to perform a multiplex
analysis to examine changes in transcript levels of 50 genes
(Figure 2; Figure S3), including those expressed in the neural
crest, neural plate, neural plate border, neural tube, ectodermal
placodes, and nonneural ectoderm, as well as genes involved in
proliferation and apoptosis. Individual half embryos (injected
versus noninjected side) were analyzed at stage 6 or stage 9 aftertal Cell 19, 460–468, September 14, 2010 ª2010 Elsevier Inc. 461
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Figure 2. NanoString nCounter Quantifica-
tion
JmjD2A loss of function affects neural crest spec-
ifier gene expression.
(A) At stage 6, the injected side of JmjD2A-MO-
treated embryos shows >25% reduction of Sox8
(gray) on the injected compared with the unin-
jected side. No significant changes were noted in
other genes.
(B) Control morpholino-injected embryos had no
significant differences between injected and unin-
jected side at stage 6.
(C) At stage 9, the expression of several neural
crest specifier genes, including Sox10 (red),
FoxD3 (blue), Sox8 (gray), and Snail2 (yellow), as
well as the signaling factor, Wnt1 (pink) were
reduced more than 25% on the JmjD2A-MO-in-
jected side (IS) compared with the uninjected
(UIS). In contrast, Twist1 (green) was upregulated
on the morpholino-injected side.
(D) Control morpholino-injected embryos had no
significant differences between injected and unin-
jected side at stage 9. Insets show fold expression
differences (mean ± SD) between IS and UIS
comparing JmjD2A-MO (n = 4) and control-MO
(n = 3) treated embryos. Asterisks (* and **) indicate
significant differences (p < 0.05 and p < 0.01,
respectively) by Student’s t test (B–D). Dotted
line represents variation greater than 25%
between IS and UIS. See also Figure S3.
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JmjD2A Is Essential for Neural Crest Specificationtreatment with JmjD2A- or control-MO (Figure 2). No significant
differences were observed at either stage between the two sides
of control-MO-treated embryos (Figures 2B and 2D), with a less
than 20% variation. As a consequence, we defined 25%
(gray dotted line on Figure 2) variation as our cutoff for statistical
significance. At stage 6, the NanoString reads collected from
four embryos showed that JmjD2A-MOcausedadownregulation
of only the Sox8 (p = 0.04) gene (inset in Figure 2A). However, by
stage 9, there was a significant reduction in gene expression for
several neural crest specifier genes, with Sox10 (p = 0.0002)
most dramatically affected, as well as significant downregulationSt10St8+ St10
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462 Developmental Cell 19, 460–468, September 14, 2010 ª2010 Elsof Sox8 (p = 0.04), FoxD3 (p = 0.04), Snail2 (p = 0.02), and Wnt1
(p = 0.01). Twist1 (p = 0.03) was the only gene significantly
upregulated (inset in Figure 2C) after JmjD2A knockdown. In
contrast, there were no significant changes in the expression
of several neural tube, ectodermal, neural plate, and border
genes, or in markers of proliferation and apoptosis.
In order to corroborate the NanoString nCounter results and
gain spatial information on expression on some of the genes
affected by the JmjD2A-MO treatment, we perfomed in situ
hybridization (Figures 3A, 3B, and 4). The results show that
JmjD2A protein knockdown profoundly diminishes expression
of neural crest specifier genes while having no effect on other
genes in the neural tube. By categorizing embryos according
to the severity of their phenotype as strong, mild, or none
(Figure S4A), we observed significant reduction between mor-
pholino-treated and control embryos in the expression of neural
crest specifier genes Sox10 (p < 0.01, n = 22), Sox9 (p < 0.01,
n = 9), FoxD3 (p < 0.05, n = 6), and Snail2 (p < 0.05, n = 8) in
premigratory and migratory neural crest cells. On the otherFigure 3. JmjD2A Loss of Function Depletes Sox10 Expression
(A) Electroporation of fluorescent JmjD2A morpholino (JmjD2A-MO) into one
side of the embryo (green staining in inset) causes a dramatic reduction in
Sox10 expression in embryos examined at stage 8+ and 10, compared with
the nonelectroporated side or control morpholinated embryos (Control-MO).
(B) Quantitation of the numbers of JmjD2A-MO-treated embryos with either
mild or strong phenotypes on the electroporated versus contralateral side
compared with those observed in control-MO-treated embryos. Asterisk indi-
cates significant differences (p < 0.01) by contingency table followed by chi-
square test. Numbers represent individual embryos.
(C) Western blots reveal specific reduction of JmjD2A protein expression on
the JmjD2A-MO-injected side (IS) compared with both the uninjected side
(UIS) and the injected side of the control-MO embryos. See also Figure S4.
evier Inc.
DA
C’
B’ D’
A’
B C
7xaPgulS9xoS FoxD3
’C’A ’D’B
F
gulS9xoS Pax7
E
FoxD3
G
* * *
F’
E’
6 6 6 4 6 4
1
2
1
6
3 4
1
0.60
0.80
1.00
yp
e 
ra
o
Strong
Mild
Non
Msx1Sox2
F’E’ 1 1 1
5
3
5
2
2 3
0.00
0.20
0.40
Ph
en
ot
y
+    - +    - +    - +    -+    -+    -
Msx1Sox2
Figure 4. JmjD2A Loss of Function Affects
Expression of Neural Crest Specifier Genes
Sox9, FoxD3, and Snail2, but Not Dorsal
Neural Tube Markers
As seen by in situ hybridization in whole mount
(A–F) or transverse section (bottom of each panel)
(A0–F0), electroporation of JmjD2A-MO causes
a significant reduction in expression of Sox9,
FoxD3 and Snail2, whereas no obvious effects
were noted for Pax7, Sox2, and Msx1. Insets
show the distribution of fluorescently labeled mor-
pholino (green). Dotted lines indicate level of
section. (G) Quantitation of the numbers of
embryos showing a phenotype on the electropo-
rated side of JmjD2A-MO (+) and control-MO ()
treated embryos. Asterisk indicates p < 0.05
versus control-MO by contingency table followed
by chi-square. Numbers represent individual
embryos. See also Figure S5.
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JmjD2A Is Essential for Neural Crest Specificationhand, we observed no significant effects on expression in the
dorsal neural tube of Pax7, Msx1, and Sox2 (n = 6). As expected,
control-MO-treated embryos had no phenotype. These results
are consistent with those observed in our NanoString experi-
ments, with the addition of the neural crest specifier gene
Sox9, for which we lacked a functional NanoString probe.
To control for the specificity of our morpholino knockdown,
rescue experiments were performed by coelectroporating the
JmjD2A-MO, located upstream of the start codon, with a vector
encoding full length JmjD2A protein (JmjD2A-H2RFP), plus
nuclear RFP expressed as an independent protein due to the
presence of an Internal Ribosome Entry Site (IRES) in the vector
(Figure 5). Coelectroporation of JmjD2A-MO plus JmjD2A-
H2RFP resulted in a 25% reduction in the severity of the
phenotype compared with coelectroporation of JmjD2A-MO
plus empty vector (H2RFP), and was not significantly different
from control-MO-treated embryos. Importantly, the rescue
effect was lost when the morpholino was coelectroporated
with the mutated JmjD2A lacking catalytic activity (DJmjD2A-
H2RFP) described above, restoring significant differences
(p < 0.01) from phenotypes observed in control-MO-treated
embryos.
To look at long-term effect of the JmjD2A depletion, we exam-
ined the formation of ganglia in the head to which the neural crest
contributes (trigeminal, geniculate, petrosal, and nodose)
(Figure S5). The results reveal a severe defect in cranial gangliaDevelopmental Cell 19, 460–468, Seformation as assayed by b-neurotubulin
(TuJ1) immunostaining at stage 16–17.
This is particularly evident in the trigem-
inal ganglion, the largest of the cranial
ganglia, which appears smaller and mal-
formed on the injected side of
JmjD2A-MO-treated embryos compared
with both the uninjected side of the
same embryo or with control-MO-treated
embryos.
Taken together, these results demon-
strate that JmjD2A is required and
remarkably specific for correct expres-sion of several neural crest specifier genes, perturbation of which
causes profound defects in neural crest derivatives. This high-
lights the importance of chromatin modifications during neural
crest development.
H3K9me3 and H3K36me3 Occupancy Regulates Neural
Crest Specifier Expression In Vivo
In order to directly determine the importance of histone
methylation in regulation of NC specifier gene expression, we
performed chromatin immunoprecipitation (ChIP) with anti-
bodies to H3K9me3 and H3K36me3 using dissected tissue
from 30 embryos. The results reveal dynamic occupancy of sites
in proximity to the transcriptional start site (TSS) of two important
neural crest specifier genes, Sox10 and Snail2 (Figure 6A).
Tissue was dissected from embryonic regions containing
neural crest precursors from gastrula stage (stages 3–4) or
from actively migrating stages (stages 10–11). Interestingly,
we observed high and moderate occupancy of H3K9me3 at
0.5 kb from the TSS of both Sox10 and Snail2 at the late
gastrula stage, respectively. This result is consistent with the
possibility that this strong epigenetic repression mark inhibits
transcription at this time point. Moreover, occupancy of
H3K36m3, generally associated with active gene transcription,
was high for b-actin and Snail2, and low for Sox10. Taken
together, the location and abundance of H3K9me3 and
H3K36me3 clearly reflects the transcriptional state of repressedptember 14, 2010 ª2010 Elsevier Inc. 463
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Figure 5. Rescue Experiment Restores Sox10 Expression
(A) Electroporation of JmjD2A morpholino (JmjD2A-MO, in green) together
with a vector containing the coding region of JmjD2A (JmjD2A-H2RFP, in red)
rescues the depletion of Sox10 expression as assayed by ISH. In contrast,
coelectroporation JmjD2A-MO plus an empty vector (H2RFP, in red) or cata-
lytically dead mutant of JmjD2A (DJmjD2A-H2RFP, in red) failed to rescue
the loss-of-function phenotype.
(B) Quantitation of the numbers of rescue experiment with either mild or strong
phenotypes on the electroporated versus contralateral side compared with
those observed in control-MO-treated embryos. Asterisk indicates significant
differences (p < 0.01) by contingency table followed by chi-square test.
Numbers represent individual embryos. See also Figure S2.
Developmental Cell
JmjD2A Is Essential for Neural Crest SpecificationSox10, Snail2 poised for activation, and active b-actin gene at
late gastrula stages.
Interestingly, the occupancy of the ‘‘repressive’’ mark
H3K9me3 near the Sox10 and Snail2 TSS was clearly reduced
by times of active neural crest migration (stages 10–11) and
approached levels similar to those observed for b-actin, consis-
tent with high expression of these genes by this stage. On the
other hand, occupancy on the H3K36me3 marks situated down-
stream of the TSS was still abundant for Snail2 and b-actin loci,
but unchanged in Sox10. These findings suggest that the deme-
thylation of H3K9me3 (repressive) marks plays an important role
in regulating expression of neural crest specifier genes during
chick development.
JmjD2A Directly Binds to Regulatory Regions of Neural
Crest Specifier Genes In Vivo
We next performed ChIP for JmjD2A as a function of develop-
mental stages using dissected tissue from 30 embryos and
analyzing by QPCR the occupancy around the TSS of Sox10,464 Developmental Cell 19, 460–468, September 14, 2010 ª2010 ElsSnail2, and b-actin genes (Figure 6B; Figure S6). Interestingly,
JmjD2A ChIP revealed stage-dependent binding to a regulatory
region located 0.5 kb from the TSS of both Sox10 and Snail2
neural crest specifier genes. During gastrulation, there was
2.6- and 4-fold changes on the input enrichment near the
Sox10 and Snail2 TSS region, respectively, relative to negative
controls situated in ORF-free intergenic regions on the same
chromosome, Chr1 (negative control for Sox10), Chr2 (negative
control for Snail2). Moreover, no differences were observed
when analyzing similar positions on the b-actin locus. In contrast
to gastrulation, we failed to detect occupancy of JmjD2A around
the TSS of the Sox10, Snail2, and b-actin genes during neural
crest migration less than 1 day later. These data demonstrate
that JmjD2A interacts in vivo in a time and location-dependent
manner on neural crest specifier genes, Sox10 and Snail2. Inter-
estingly, the direct interaction of JmjD2A with neural crest
regulatory regions correlates well with the histone modifications
described in Figure 5, consistent with the idea that it derepresses
those genes through H3K9me3 demethylation.
JmjD2A Knockdown Inhibits Demethylation
of H3K9me3 on the Sox10 Promoter
To narrow the timing of JmjD2A action on neural crest genes, we
performed ChIP with H3K9me3 and JmjD2A antibodies using
dorsal neural tubes from embryos collected at stage 8 and 9 in
order to explore when H3K9me3 is demethylated and how the
timing correlates with binding of JmjD2A to the Sox10 promoter.
The time period between stage 8 and 9 is key because it corre-
lates with the first appearance of Sox10 transcripts in the neural
crest by both in situ hybridization and quantitative PCR. The
results reveal a fine time window of association between
the JmjD2A and H3K9me3 occupancy on the Sox10 promoter
(Figures 7A and 7B). Interestingly, JmjD2A binds efficiently to
0.5 kb on Sox10 genes at stage 8, but not at stage 9 by which
time its association is not different from the negative control
region (Chr1 nc). In a similar manner, the region 0.5 kb from
theTSSofSox10genewashighly occupiedbyH3K9me3at stage
8, but dropped precipitously at stage 9 to levels comparable to
those observed on surrounding region (1 and 0.5 kb from the
TSS). These results reveal a rapid and dynamic process whereby
JmjD2A is preloaded on the Sox10 locus and leaves upon deme-
thylation, thus permitting activation of Sox10 transcription.
Given the dynamic changes in both JmjD2A and H3K9me3
occupancy of the Sox10 promoter between stages 8 and 9, we
examined the effects of JmjD2A-MO on Sox10 promoter occu-
pancy at these key stages (Figures 7C and 7D). As predicted,
the occupancy JmjD2A was completely abolished on the
promoter in JmjD2A-MO compared with both control-MO and
untreated embryos collected at stage 8. This is not surprising
given the lack of JmjD2A protein in the JmjD2-MO embryos.
On the other hand, H3K9me3 occupancy of the Sox10 promoter
clearly increased in JmjD2A-MO-treated embryos collected at
stage 9, with highest levels at 0.5 kb from the TSS. In contrast,
control-MO embryos had similar levels at all positions analyzed,
scoring values similar to those observed on untreated embryos
at stage 9. As a further control, we used 0.5 kb from the TSS
of b-actin gene, and observed no differences in H3K9me3 asso-
ciation between JmjD2A-MO and control-MO-treated embryos
(Figure 7E). These results conclusively demonstrate that JmjD2Aevier Inc.
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Figure 6. Dynamic Changes in H3K9me3, H3K36me3, and JmjD2A Occupancy on Neural Crest Specifier Genes during Chick Development
In Vivo
(A) Chromatin immunoprecipitation (ChIP) assay was used to assess the H3K9me3 and H3K36me3 occupancy around the transcriptional start site (TSS) of
Sox10, Snail2, and b-actin. Three independent experiments were performed for each stage. The vertical axis represents percentage input (ChIP enriched/input)
and horizontal axis the distance from the TSS in kilobases (kb). Schematic diagrams represent primer location over the three analyzed genes and numbers repre-
sent approximate distance in kilobases from the TSS. Cartoons schematize the two stages (stages 4–5 and 10–11) of analysis, with red indicating the region of
tissue dissected and collected for ChIP. One representative sample is depicted per stage. The results show high occupancy of H3K9me3 at0.5 kb from the TSS
of Sox10 and Snail2 genes at stage 3–4. This repressive mark appears to be eliminated at stage 10–11. In contrast, both Snail2 and b-actin genes shown high
abundance of the active mark H3K36me3, mostly downstream of the TSS.
(B) ChIP assays assessed binding of JmjD2A at 0.5 kb from the Sox10 and Snail2 TSS. The graphs show a mean ± SD of three independent experiments for
each stage. At stage 3–4, JmjD2A significantly binds to both Sox10 (0.006% input) and Snail2 (0.007% input), when compared with two distant, control regions in
their respective chromosome 1 (Chr1nc, 0.002% input) and 2 (Chr2nc, 0.003% input), as well as with b-actin locus (0.003% input). At stage 10–11, this binding
was greatly reduced to 0.002% and 0.003% input on the Sox10 and Snail2 genes, respectively. Asterisk indicates p < 0.05 versus respective negative control by
paired Student’s t test. See also Figure S6.
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JmjD2A Is Essential for Neural Crest Specificationactivity is responsible for demethylation of H3K9me3 at 0.5 kb
from the TSS of Sox10 gene which in turn derepresses expres-
sion of Sox10 transcripts.
DISCUSSION
Jumonji family members have been shown to function as power-
ful regulators of epigenetic events in cell culture (Nottke et al.,
2009). However, little has been known about their roles and
mechanism of action in the context of the whole organism. In
the present work, we demonstrate that the Jumonji family
member, JmjD2A, is critical for embryonic development, playing
a specific role in allowing neural crest gene expression at the
appropriate developmental time. This dramatic stage-depen-
dent regulation of gene expression is made possible due to
appropriate histone modifications. Thus, Jumonji-dependent
chromatin modification can be used to dynamically regulate
rapidly changing gene regulatory networks such as the one
underlying neural crest formation.
By specifically affecting the neural crest specifier module, our
data place JmjD2A as a modulator that functions upstream ofDevelopmenneural crest specifier genes. However, there is an intriguing delay
between JmjD2A occupancy and reduction of H3K9me3 on the
Sox10 locus, opening the possibility that other factors need to be
recruited to the TSS. In this critical position, JmjD2A acts on
neural crest precursors that are retained in a stem cell-like state
but poised to initiate transcription upon removal of a repressive
H3K9me3 mark. In this way, neural crest cells that are induced
during gastrulation only initiate a bona fide neural crest program
during neurulation.
Current thinking regarding the histone code involved in
controlling differential methylation states suggests that
H3K9me3 is linked to ‘‘silent’’ genes or pericentric heterocroma-
tin (Peters et al., 2002), whereas H3K36me3 is linked to tran-
scriptional elongation (Li et al., 2007) and suppression of
inappropriate transcription (Carrozza et al., 2005; Keogh et al.,
2005). Furthermore, H3K36me3 is generally restricted to the
coding region downstream for the TSS, and is particularly en-
riched in exons. Our data suggest that the balance between
bivalent JmjD2A histone targets, H3K9me3 and H3K36me3,
reflecting repressive and activating marks respectively, may
underlie the fine tuning that controls the timing of execution oftal Cell 19, 460–468, September 14, 2010 ª2010 Elsevier Inc. 465
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Figure 7. JmjD2AActivity Is Responsible for
Derepression of Sox10 by Demethylating
H3K9me3
ChIP was used to assay the occupancy of JmjD2A
andH3K9me3 on the Sox10 gene from stage 8 and
9 wild-type or morpholinated embryos. Two to
three independent experiments were performed
at each stage using ten dorsal neural tubes per
experiment. One representative sample is de-
picted per stage. The graphs show a mean ± SD.
(A) JmjD2A occupancy at 0.5 kb from the TSS
was high at stage 8 compared with a distant region
in the same chromosome (Chr1nc). By stage 9,
however, this binding was greatly reduced to
values similar to those at Chr1nc.
(B) Similarly, H3K9me3 occupancy at0.5 kb from
the TSS was high at stage 8 but reduced by stage
9, reaching values similar to surrounding positions
(1 and 0.5 kb from the TSS).
(C) JmjD2A-MO completely abolished occupancy
of JmjD2A at stage 8, reaching values similar those
observed on the negative control Chr1nc.
(D) In JmjD2A-MO-treated embryos, H3K9me3
occupancy at stage 9 remained high on the areas
surrounding the TSS when compared with
Control-MO-treated embryos.
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However, even when we observed high H3K36me3 occupancy
at the 30 region on actively transcribed genes (e.g., Snail2 and
b-actin), we failed to observe a similar pattern on the Sox10
gene at stages of active transcription. An intriguing possibility
in the case of Sox10 in neural crest cells is that the normal role
of H3K36me3 is replaced by another epigenetic mark that allows
it elongation, such as, H3K79me2 which also is associated with
active transcription (Morillon et al., 2005; Schubeler et al., 2004).
A similar bivalent regulation between repressive (H3K27me3)
and activating (H3K4me3) marks has been described in a large
set of developmentally important genes in embryonic stem cells
in vitro. Moreover, the activation of some of these genes corre-
lates well with the demethylation of H3K27me3 (Azuara et al.,
2006; Bernstein et al., 2006). These similarities raise the possi-
bility that the flavor of the histone mark may regulate the degree
of a cell’s multipotency. Genes that are repressed in multipotent
cells contain distinct bivalent H3K9me3/H3K36me3 marks that
render them poised for activation, and are distinguishable from
those required for later differentiation genes. In fact, H3K9me3
and H3K36me3 marks can discriminate between genes that
are expressed (H3K36me3) or stably repressed (H3K9me3). As
a consequence, they may reflect the cell’s state and fate poten-
tial (Mikkelsen et al., 2007). To date, it remains unknown whether
JmjD2A favors H3K9me3 or H3K36me3 sites in vivo. This opens
the possibility that JmjD2A may form complexes with different
proteins depending upon its local and changing intracellular
environment. A similar scenario has been suggested previously
for other demethylases (Metzger et al., 2005; Shi et al., 2003).
Our observation that JmjD2A is associated with key neural
crest specifier genes gives an additional and dynamic level of
complexity to the neural crest gene regulatory network (Sauka-
Spengler and Bronner-Fraser, 2008), emphasizing the impor-
tance of chromatin modification in spatial and temporal control
of gene expression during development. Furthermore, these466 Developmental Cell 19, 460–468, September 14, 2010 ª2010 Elsfindings highlight the intriguing possibility that repressive histone
marks may underlie the latency of the multipotent state of neural
crest precursors between induction and overt morphological
manifestation of the mature state.
EXPERIMENTAL PROCEDURES
Embryos
Fertilized chicken eggs were obtained from local commercial sources and
incubated at 37C to the desired stages according to the criteria of Hamburger
and Hamilton. For in situ hybridization (ISH), embryos were fixed overnight in
4% paraformaldehyde (PFA) at 4C, washed in PTW (PBS-DEPC-treated con-
taining 0.1% Tween) and dehydrated in a MeOH/PTW series at room temper-
ature before being stored at 20C in 100% MeOH.
RNA Preparation and QPCR
RNA was prepared from individual embryos (n = 3) using RNAqueous-Micro
isolation kit (Ambion) following manufacturer’s instruction. The obtained
RNA was treated with DNaseI amplification grade (Invitrogen) and then
reversed-transcribed to cDNA with SuperScript III (Invitrogen) using random
hexamers. QPCR was performed using the 96-well plate ABI 7000 QPCR
machine in a TaqMan assay (Applied Biosciences) with Sybrgreen Itaq Super-
mix with ROX (Bio-Rad), 150–450 nM of each primer, and 200–500 ng of cDNA
in a 25 ml reaction volume. During the exponential phase of the QPCR reaction,
a threshold cycle (CT) and baseline was set according to the protocols of
Applied Biosystems. The results for different samples were then interpolated
on a line created by running standard curves for each primer set and then
normalized against the GADPH housekeeping gene. These calculations were
performed according to the standard curve assay method which is detailed
in the Applied Biosystems protocols. Three replicates of every sample and
points of the standard curve were loaded.
Electroporation of Antisense Morpholinos and Vectors
Two antisense morpholinos to JmjD2A were designed, one near the ATG
codon (50-TGAGGCTCTCCAGCTCCGAGGCCAT-30) and the second located
38 nucleotides upstream of the start codon (50-CGGTCAGCTCCGCGTC
CCGCTTCTT-30 ), with both yielding similar results. Injections of
fluorescein-tagged morpholino (1 mM plus 0.3 mg/ml of plasmid DNA) and
pCIG -H2RFP, -JmjD2A-H2RFP, and/or -DJmjD2A-H2RFP (catalyticallyevier Inc.
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and T289B) vectors were performed by air pressure using a glass micropipette
targeted to the presumptive neural crest region at stages 4–5. Stages 4–5 elec-
troporation was conducted on whole chick embryo explants placed ventral
side up on filter paper rings. The morpholinos and vectors were injected on
the left side of the embryo and platinum electrodes were placed vertically
across the chick embryos and electroporated with five pulses of 7 V in
50ms at 100ms intervals. Embryoswere cultured in 0.5ml of albumen in tissue
culture dishes to reach the desired stages. Embryos were then removed and
fixed overnight in 4% PFA at 4C. Embryos were placed in PBS, viewed and
photographed as whole mounts using a fluorescence stereomicroscope to
evidence electroporation efficiency. Embryos used for ISH were dehydrated
in a MeOH/PTW series at room temperature before being stored at 20C in
100% MeOH.
NanoString nCounter
Individual half of embryos treated with Control-MO and JmjD2A-MO were dis-
aggregated in lysis buffer (Ambion) and stored at 80C. The total RNA from
the lysates were then allowed to hybridize with the capture and reporter probe
and incubating overnight at 65C according to nCounter Gene Expression
Assay Manual. After the washes, the purified Target/Probe complexes were
eluted off and immobilized in the cartridge for data collection carried out in
the nCounter Digital Analyzer.
In Situ Hybridization
Whole-mount chick ISH was performed as previously described (Acloque
et al., 2008; Wilkinson, 1992). Linealized plasmidic DNA templates used for di-
goxigenin-labeled RNA probes were JmjD2A, JmjD2B, JmjD2C, Sox10, Sox9,
FoxD3, Snail2, Pax7, Msx1, and Sox2. Embryos were imaged as a whole
mount and after were transverse sectioned at 14–16 mm in a cryostat.
Cell Death and Proliferation
TUNEL labeling was performed using the TMR-In Situ Cell Death kit (Roche)
and subsequently immunostained with the proliferation marker Phosphohi-
stone 3 (rabbit anti-PH3, 1:500), and then detected using the secondary Alexa
Fluor goat anti-rabbit 350 (1:1000). Cells were counted in the dorsal neural tube
of both JmjD2A-MO and Control-MO, and expressed as a ratio between in-
jected versus uninjected side.
Chromatin Immunoprecipitation
Cells were extracted from presumptive neural plates and dorsal-rostral
area (see cartoon in Figure 4) from 30 embryos on three independent exper-
iments at stages 3–4 and 10–11, respectively. The cells were then cross-
linked and sonicated in an average size of 300–800 bp. Samples were split
into five tubes for Input sample, mock control (rabbit anti-IgG) and target
antibodies (anti-JmjD2A, anti-H3K9me3, and anti-H3K36me3, Abcam)
bound to Protein A-magnetic beads (Invitrogen). The complexes were
magnetically isolated, eluted, and crosslink reversed. The DNA was purified,
precipitated and finally used as a template for QPCR analyzes (see Table S1
for list of primers). Every sample was load by three replicates each. The
results were quantified using DDCt method and calculated according to
manufacturer’s instructions (Applied BioSystems). On the ChIPs performed
on morpholino-treated embryos, ten dorsal neural tube were dissected
from JmjD2A-MO and Control-MO embryos at stages 8 and 9, and pro-
cessed as mentioned above.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/j.
devcel.2010.08.009.
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